Mealey's (April 14, 2023, 12:19 PM EDT) -- WASHINGTON, D.C. — The Federal Circuit U.S. Court of Appeals upheld findings by the Patent Trial and Appeal Board that 22 claims of a patented method of providing stable nucleic acid lipid particles (SNALP) are anticipated by prior art owned by the same appellant....